Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health – Europe
Stephanie Becker, Senior Editor at The Lancet Regional Health – Europe, shared on LinkedIn:
”Exciting advances in stroke research were front and centre at ESOC 2026 in Maastricht, where more than 4000 delegates from 96 countries gathered to discuss the future of stroke prevention, intervention, and recovery.
Our conference highlights are now live in The Lancet Regional Health – Europe.
I was delighted to attend this conference held by the European Stroke Organisation, meeting enthusiastic and driven researchers and hearing about the latest research in the field that could help shape the next generation of stroke care.
Some standout findings included:
- The HOPE trial, showing that personalised blood pressure targets after thrombectomy may significantly improve functional recovery after acute ischaemic stroke.
- New OCEANIC-STROKE analyses suggesting that asundexian not only reduces recurrent stroke risk, but may also lessen stroke severity and disability.
- The DISTALS trial, demonstrating promising results for a novel low-profile stent-retriever designed specifically for distal vessel occlusions.
- ATILA trial findings showing that low-dose tirofiban reduced acute in-stent thrombosis by more than half following thrombectomy and carotid stenting.
- The ATLAS meta-analysis, providing compelling evidence that patients with large-core ischaemic stroke can still benefit from endovascular thrombectomy — challenging long-standing assumptions in the field.
What stood out most at this year’s meeting was the momentum across stroke research: from refining thrombectomy strategies to improving secondary prevention and expanding treatment eligibility for patients previously thought unlikely to benefit.
A fascinating and energising few days for everyone working in cerebrovascular medicine.
Read my full conference highlights.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 09:20Jan Sloves: Medial Thigh Venous Perforators – Why Diameter Isn’t the Whole Story
-
Oct 5, 2026, 09:16Emmanuele Kouvousis: ASH Sets New Standards for Diagnosing Iron Deficiency
-
Oct 5, 2026, 09:12Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
-
Oct 5, 2026, 09:06Edward Lee Carter: NOTION-4 – HALT and Clinical Outcomes
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026